1. Sireesha K, Rajasekhar P, Ramachandra B, Prabha RJJhwicI. Species of Bacillus as Potential Probiotics.2582:7421.
2. Elshaghabee FM, Rokana N, Gulhane RD, Sharma C, Panwar HJFim. Bacillus as potential probiotics: status, concerns, and future perspectives. 2017:1490.
3. Celandroni F, Vecchione A, Cara A, Mazzantini D, Lupetti A, Ghelardi EJPo. Identification of Bacillus species: Implication on the quality of probiotic formulations. 2019;14(5):e0217021.
4. Joshi S, Udani S, Sen S, Kirolikar S, Shetty AJTPidj. Bacillus Clausii septicemia in a pediatric patient after treatment with probiotics. 2019;38(9):e228-e30.
5. Khatri I, Sharma G, Subramanian SJBm. Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina®, and insights into its probiotic properties. 2019;19(1):1-15.
6. Bevilacqua A, Petruzzi L, Sinigaglia M, Speranza B, Campaniello D, Ciuffreda E, et al. Effect of physical and chemical treatments on viability, sub-lethal injury, and release of cellular components from Bacillus Clausii and Bacillus Coagulans spores and cells. 2020;9(12):1814.
7. Biagioli M, Carino A, Di Giorgio C, Marchianò S, Bordoni M, Roselli R, et al. Discovery of a novel multi-strains probiotic formulation with improved efficacy toward intestinal inflammation. 2020;12(7):1945.
8. Paparo L, Tripodi L, Bruno C, Pisapia L, Damiano C, Pastore L, et al. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection. 2020;10(1):1-10.
9. Morelli L, Pellegrino PJBM. A critical evaluation of the factors affecting the survival and persistence of beneficial bacteria in healthy adults. 2021;12(4):321-31.
10. Acosta-Rodríguez-Bueno CP, Abreu y Abreu AT, Guarner F, Guno MJV, Pehlivanoğlu E, Perez MJAiT. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. 2022:1-21.